[{"Assets_0_Q1_USD":247367000.0,"CommonStockSharesOutstanding_0_Q1_shares":14655000.0,"EarningsPerShareBasic_1_Q1_USD":0.38,"EarningsPerShareDiluted_1_Q1_USD":0.37,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":15460000.0,"NetIncomeLoss_1_Q1_USD":5493000.0,"StockholdersEquity_0_Q1_USD":230028000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":15043000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":14576000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170504"}]